SC 13G/A: NEUROONE MEDICAL TECHNOLOGIES Corp
Ticker: NMTC · Form: SC 13G/A · Filed: Nov 25, 2024 · CIK: 1500198
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by NEUROONE MEDICAL TECHNOLOGIES Corp.
Risk Assessment
Risk Level: low
Filing Stats: 941 words · 4 min read · ~3 pages · Grade level 6.9 · Accepted 2024-11-26 08:42:10
Key Financial Figures
- $0.001 — ame of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 64130
Filing Documents
- nmtc13ga1.htm (SC 13G/A) — 28KB
- 0000935836-24-000743.txt ( ) — 29KB
Ownership
Item 4. Ownership. See Items 5-9 and 11 of the cover page. The shares of the Stock reported herein consist of 1,851,588 shares of Common Stock and warrants to purchase 208,334 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentages reported in this Schedule 13G are based on 30,811,880 shares of Common Stock outstanding as of August 13, 2024, as reported in the Form 10-Q filed by the Issuer on August 14, 2024.
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
Ownership of More than Five Percent on Behalf of Another Person
Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group. Not applicable
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group Not applicable.
Certification
Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated:November 25, 2024 /s/ Laurence W. Lytton Laurence W. Lytton